Hepatitis B virus (HBV) infection is associated with chronic liver diseases, cirrhosis and hepatocellular carcinoma, liver failure and death. The prevalence of Hepatitis B virus carrier and infectivity status and social characteristics among three hundred and ten pregnant women in Logo LGA, Benue State, Nigeria, was determined through random anonymous testing of volunteers attending antenatal clinics of different hospitals within the community. Thirty of three hundred and ten blood samples tested positive for HBV infection. 11.9% were in the 3 rd trimester of their pregnancy and 58.1% were within the age bracket of 21-30 years. Illiterates women constituted 14.4% of those sampled while civil servants were 6.7%. HBV carrier status was determined by the presence of Hepatitis B surface antigen (HBsAg). Repeated reactive samples were confirmed by Enzyme linked immounosorbent assay (ELISA) Kit (Diagnostic Automation, Inc., USA). Maternal HBV infectivity status was determined by testing all HBsAg positive samples for the presence of hepatitis B e antigen (HBeAg). A total of thirty (9.7%) pregnant women identified as carriers of HBV and eleven of the thirty tested positive for HBeAg. Hence, 3.6% (11/310) of the entire study population was found to have high viral replication as well as high risk of transmitting HBV to their neonates. The frequency of HBV carrier did not vary with age, however, it varies significantly with the previous use of contraceptives and the anaemic status of the subjects (P< 0.05) .This study demonstrates the endemicity of HBV infection in Logo and high infectivity rate, suggest that HBV is likely to be acquired by both vertical and horizontal means of transmission. Testing for HBsAg is recommended for all pregnant women at first prenatal visit so that positive mothers receive prompt intervention.
INTRODUCTION
Hepatitis B virus is a blood borne and sexually transmitted pathogen that is spread through percutaneous and mucosal exposure to infected blood and body fluids. The virus was first discovered as "Australia antigen" later named Hepatitis B surface antigen (HBsAg), in patient blood. Hepatitis B e antigen (HBeAg) was identified several years later as a marker for patients at high risk for transmission of the disease (1). The virus has caused several epidemics in parts of Africa and Asia (2) and approximately 350 million persons worldwide are infected with the virus (3, 4, 5, 6) , resulting in 2 million deaths annually.
When a pregnant woman is infected with HBV there is a chance she may infect her foetus. It has been reported that 10-20% of women seropositive for HBsAg transmit the virus to their neonates, but in women who are seropositive for both HBsAg and HBeAg; vertical transmission is approximately 90% (7, 8) .
Nigeria is classified among the countries highly endemic for viral hepatitis. Currently about 18 million Nigerians are infected (9, 10) . Many of these people may not be aware of the infection and hence fail to seek appropriate medical attention therefore progressing to chronic liver disease, cirrhosis and hepatocellular carcinoma, liver failure and death. Similarly when pregnant women are involved they constitute a serious health risk not only to their unborn child but the society at large.
Although, studies have been carried out on HBV in other parts of the country, information is scarce on the prevalence of HBV among pregnant women in the rural parts of Benue state, in particular Logo
LGA. The aim of this study therefore is to determine the prevalence of hepatitis B virus carrier and infectivity status of pregnant women attending ante natal clinics in Logo LGA of Benue state, Nigeria. 
MATREIALS AND METHODS

AREA OF STUDY
STUDY DESIGN
The study was a hospital based descriptive cross sectional survey conducted between 1 st July, 2012 and 30th April, 2013 at the antenatal clinics within Logo LGA, Benue State Nigeria. On every antenatal day, the pregnant women were given health talk on HIV/AIDS and hepatitis infections and were advised on the need to know their status. Only consenting attendees were recruited and included in the study.
SUBJECTS
Three hundred and ten pregnant women attending antenatal clinics in different hospitals in Logo Local Government were randomly selected from the clinic centres. Their specimens were retrieved and reviewed for analysis after informed consent. Information obtained from the case note included demographic characteristics, risk factors, blood group, haematocrit, and results of serological markers for hepatitis B virus.
Pre-structured questionnaires were administered to three hundred and ten consenting pregnant women. Each questionnaire was designed to obtain demographic data such as age, occupation and educational status. Risk factors information were also obtained which include the stages of pregnancy, history of blood transfusion, and history of STIs, whether or not respondents share sharp objects like razors and toothbrushes.
ETHICAL CONSIDERATIONS
Ethical approval was gotten at the Benue state Ministry of Health and Human Services, Makurdi through the Medical Director of the General Hospital Ugba and the Logo Local Government Health Department.Informed consent was obtained from the from the antenatal clinic attendees with assurance that all information obtained would be treated as confidential and would be used for the purpose of this study only.
SAMPLE SIZE AND ITS DETERMINATION
Using the Kish (11) formula: n= (z 2 pq/d 2 ) for determining adequate sample size and further correcting for population less than 10,000 using nf = n/1+(n/N) (12), 310 respondents were enrolled for this survey.
COLLECTION OF BLOOD SAMPLES / SERUM PREPARATION
Hepatitis B surface antigen (HBsAg) detection was done using the in vitro diagnostic kit manufactured by Cal -Tech Diagnostic, Inc. USA. The test kit (dipsticks) is a rapid immunochromatographic assay designed for qualitative determination of HBsAg in human serum or plasma. Assays were carried out at room temperature. The sera samples were removed from the freezer and left at room temperature to thaw. The test strips were removed from their foil pouches and immersed into serum samples with arrows pointing towards the samples. The strips were taken out after about 10secs and placed on a clean, dry, non-absorbent surface. This is to allow time for the reaction to take place. It was observed that the specimen was absorbed into the test strips and moved by capillary action upward towards the control line. Results were read after 10mins post immersion. Positive samples generated a colour band in the test region of the strips and another in the control region while negative samples had a colour band in the control regions only.It utilizes a combination of monoclonal and polyclonal antigen body to selectively detect elevated level of HBsAg in serum/plasma. The test was carried out and interpreted according to the manufacturer's instructions and in the laboratories of the hospitals were the samples were collected.
Reactive samples were stored in a freezer and further confirmed for HBsAg in the Innovative Biotechnology Laboratory Keffi where HBsAg positive samples were tested for HBeAg, associated with infectivity and active virus replication; using commercially available enzyme linked immounosorbent assay kit ELISA (Diagnostic Automation Inc. USA)
DATA ANALYSIS
Data from the questionnaires were analyzed using SPSS version 15.0. Chi-square was used to compare significant differences between HBV prevalence and risk factors. Significance was determined at P < 0.05 at 95% Confidence interval.
RESULTS
The results of the Seroprevalence study are presented in table 1, showed that of the three hundred and ten (310) pregnant women tested, 30 (9.7%) pregnant women were seropositive for Hepatitis B surface antigen (HBsAg). Eleven (11) out of the thirty (30) pregnant women were identified as HBeAg positive. Hence, 3.6 % (11/310) of the entire study population was positive for HBeAg.
With respect to age, the results showed that there is an increase in HBsAg titres with increase in age up to 30 years followed by a decline. Statistically, however, there was no significant association ( x 2 =1.960; p = 0.5808) between age and seroprevalence of HBV infection.
The level of educational attainment and occupation and seroprevalence of the pregnant women are presented in table 2.It showed that there is an inverse relationship between educational attainment of the women and seroprevalence of HBV infection. Details show that women with high prevalence of the infection are illiterates (14.4%) while those with some levels of education had lower prevalence even though there was no significant association (x 2 = 4.213 p = 0.239). Similarly, the results revealed that house wives had higher prevalence (13%) than the other women considered in this study. Despite this observation, no significant association (x 2 =5.86 p = 0.119) between HBV infection and the occupation of the women. There was no significant association between infection and pregnancy stages of the women( x 2 = 2.239 p = 0.326), (Table 3) . The frequency of HBV carriers did not vary significantly with blood transfusion, sharing needles, Alcoholic consumption, Herbal medicine use and history of STI(s). However, there was a significant frequency variation in the distribution of HBsAg and contraceptive use subjects (x 2 = 7.212 p = 0.007) and anaemic and non-anaemic subjects (x 2 = 7.143 df = 1 p 0.008) ( Table 4) . HBV carriers also decrease as anaemia decreases significantly (x 2 = 15.048 df = 6 p = 0.0199), (Table 5) . Among all the contraceptive devices used previously by the subjects, only users of oral pills were positive for HBeAg. (Table 6) .
DISCUSSION
This study showed that the prevalence of hepatitis B virus (HBV) infection in apparently healthy pregnant women attending antenatal clinics in the major hospitals within Logo LGA, Benue State was 9.7%, falls within figures reported for other African countries. This corroborates the World Health Organization (13) report for Nigeria as highly endemic area with prevalence greater than 8%. The HBsAg seropositivity of 9.7% among pregnant women in Logo shows that Logo like other areas in Nigeria is endemic for HBV infection.
In related studies in different parts of Nigeria, higher prevalence rates of 13.8% were reported among pregnant women in Lagos (14) (20) and 2.89% in 2006 (21) and 5.7% in Ilorin (22) . The result of this study is higher than the 6.3% reported in pregnant women in Tanzania (23) and 3.7% in Ethiopia (24) , showing that variations exist within the same continent of Africa.
Similar studies in other parts of the world were 10% in India (25) , 12% in Taiwan (26) and 17.3% in Burkina Faso (27) agreeing with Juszozyk (28) that the global prevalence of chronic HBV infection varies, highest in Africa, Asia and the western Pacific (>8%) to lowest in western Europe, North America and Australia. HBeAg seroprevalence of 3.6% in the entire study population implies that one out of every three HBV carriers (11/310) is at high risk of transmitting HBV to her neonate as well as higher chances of chronicity. This is alarming but tallies with the result of Olubuyide et al (29) , who found 3.4% among HBsAg positive doctors and dentist at university teaching hospital Ibadan. However, it is very high when compared with 0.8% found by Madzine et al, (30) 
CONCLUSION
Since the virus can be transmitted from infected mother to the offspring especially at birth, the presence of HBV infection in women in general and pregnant women in particular calls for concern. Free screening of all pregnant women should be incorporated in the antenatal and post-natal infection programmes in hospitals to prevent potential infection of the infants by their infected mothers. The use of other HBV infection serological markers such as anti HBs, anti HBc, and HBe as well as HIV coinfection and cases of HBsAg positive women and the effects of the positivity on their babies is advocated for further studies.
